My idea of whats happening in the stem cell sector. And I mean MESO, ATHX and PSTI specifically because they are really the only relevant cell companies with different patents
All 3 have announced excellent news that should have blown up stock price.All 3 are close to finishing phase 3 trials and probably successfully.
All 3 have not partnered with big pharma yet. Billions are needed for mass comercilization and huge manufacturing capacity.
so all good news is shorted with naked shorted,shares not declared borrowed.
This will keep the small stem cell company broke and not able to raise money for manufacturing.
Also these small companies do not have the logistics to go it alone.
Big pharma has been lowballling offers for 10 years. And they continue to do it.
Gruenthall back partnership was very encouraging.
So we wait for partnership deals to be finished before we start,the big accent to 10 or 20 bucks
On the other hand we wait 2 years for money to come in we will be rewarded also.
MSB Trading - 2020, page-4867
-
- There are more pages in this discussion • 18,294 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.080(8.25%) |
Mkt cap ! $1.196B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $4.669M | 4.530M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 20154 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 4133 | 2 |
View Market Depth
| Last trade - 15.59pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |